Patents by Inventor Monica Zepeda

Monica Zepeda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8329671
    Abstract: Methods and compositions for reducing or inhibiting dermal scarring by expressing p21WAF1/Cip1 in a wound site are provided.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: December 11, 2012
    Assignee: Canji, Inc.
    Inventors: Danling Gu, Monica Zepeda
  • Publication number: 20110129534
    Abstract: Methods and compositions for reducing or inhibiting dermal scarring by expressing p21WAF1/Cip1 in a wound site are provided.
    Type: Application
    Filed: February 9, 2011
    Publication date: June 2, 2011
    Applicant: Canji, Inc.
    Inventors: Danling Gu, Monica Zepeda
  • Publication number: 20100130958
    Abstract: The present invention provides infusion devices and methods for subcutaneous delivery of high viscosity fluids. The devices and methods described are innovative subcutaneous infusion systems that allow for the rapid delivery of viscous therapeutic fluids while avoiding adverse side effects and promoting patient comfort. The devices and methods described are also useful for rapid delivery of high volumes of therapeutic fluids.
    Type: Application
    Filed: November 26, 2008
    Publication date: May 27, 2010
    Inventors: David Kang, Monica Zepeda
  • Publication number: 20090142397
    Abstract: Methods and compositions for reducing or inhibiting dermal scarring by expressing p21WAF1/Cip1 in a wound site are provided.
    Type: Application
    Filed: November 10, 2008
    Publication date: June 4, 2009
    Applicant: Canji, Inc.
    Inventors: Danling GU, Monica Zepeda
  • Patent number: 7465442
    Abstract: Methods and compositions for reducing or inhibiting dermal scarring by expressing p21WAF1/Cip1 in a wound site are provided.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: December 16, 2008
    Assignee: Canji, Inc.
    Inventors: Danling Gu, Monica Zepeda
  • Publication number: 20080107643
    Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.
    Type: Application
    Filed: October 5, 2007
    Publication date: May 8, 2008
    Inventors: Joseph Hedrick, Bernhard Homey, Alain Vicari, Monica Zepeda, Albert Zlotnik
  • Publication number: 20060269993
    Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.
    Type: Application
    Filed: February 9, 2006
    Publication date: November 30, 2006
    Inventors: Joseph Hedrick, Bernhard Homey, Alain Vicari, Monica Zepeda, Albert Zlotnik
  • Publication number: 20050271623
    Abstract: Methods and compositions for reducing or inhibiting dermal scarring by expressing p21WAF1/Cip1 in a wound site are provided.
    Type: Application
    Filed: November 23, 2004
    Publication date: December 8, 2005
    Applicant: Canji, Inc.
    Inventors: Danling Gu, Monica Zepeda
  • Publication number: 20020111290
    Abstract: Methods for treating, diagnosing, or evaluating various medical conditions. Correlations of chemokine or receptor expression with medical status are provided.
    Type: Application
    Filed: November 27, 2001
    Publication date: August 15, 2002
    Inventors: Bernhard Homey, Monica Zepeda, Albert Zlotnik